Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

BACKGROUND: Uveal melanoma (UM) is highly refractory to treatment with dismal prognosis in advanced stages. The value of the combined checkpoint blockade with CTLA-4 and PD-1 inhibition in metastatic UM is currently unclear. METHODS: Patients with metastatic or unresectable UM treated with ipilimuma...

Descripción completa

Detalles Bibliográficos
Autores principales: Heppt, Markus V., Amaral, Teresa, Kähler, Katharina C., Heinzerling, Lucie, Hassel, Jessica C., Meissner, Markus, Kreuzberg, Nicole, Loquai, Carmen, Reinhardt, Lydia, Utikal, Jochen, Dabrowski, Evelyn, Gesierich, Anja, Pföhler, Claudia, Terheyden, Patrick, Thoms, Kai-Martin, Zimmer, Lisa, Eigentler, Thomas K., Kirchberger, Michael C., Stege, Henner M., Meier, Friedegund, Schlaak, Max, Berking, Carola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854774/
https://www.ncbi.nlm.nih.gov/pubmed/31722735
http://dx.doi.org/10.1186/s40425-019-0800-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854774/
https://www.ncbi.nlm.nih.gov/pubmed/31722735
http://dx.doi.org/10.1186/s40425-019-0800-0

Ejemplares similares